AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2024
May 23, 2024
30583_dirs_2024-05-23_a8b11a11-21d7-4fbb-ab00-f9fdb47f1b5e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2024-05-21
Reporting Person: Enyedy Mark J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-21 | Common Stock | A | 4720 | — | Acquired | 6900 | Direct |
Footnotes
F1: Restricted stock units granted on May 21, 2024. Price not applicable.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19